The global Prostaglandin D2 Receptor 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Prostaglandin D2 Receptor 2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostaglandin D2 Receptor 2 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Prostaglandin D2 Receptor 2 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Prostaglandin D2 Receptor 2 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan Plc
Brickell Biotech, Inc.
Ligand Pharmaceuticals, Inc.
Merck & Co., Inc.
Novartis AG
Oxagen Limited
Panmira Pharmaceuticals, LLC.
Pulmagen Therapeutics LLP
Taisho Pharmaceutical Holdings Co., Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
OC-2417
MK-1029
BBI-5000
ADC-7405
Others

Segment by Application
Atopic Dermatitis
Allergic Asthma
Chronic Obstructive Pulmonary Disease
Others